Brief: Sartorius Sharpens Strategy With Biopharma Focus, Sets New Midterm Growth Targets

Sartorius AG

17/03/2026 06:06

March 17 (Reuters) - Sartorius AG SATG.DE:

EQS-NEWS: SARTORIUS SHARPENS STRATEGY WITH BIOPHARMA FOCUS AND SETS NEW MID-TERM GROWTH TARGETS

SARTORIUS AG - EXPECTS ADDRESSABLE MARKETS TO GROW 7-9% PER YEAR MEDIUM TERM

SARTORIUS AG - EXPECTS LAB PRODUCTS & SERVICES DIVISION MARGIN IMPROVEMENT OF 20-30 BPS PER YEAR

SARTORIUS AG -  EXPECTS COMPANY TO CONSISTENTLY OUTGROW ITS ADDRESSABLE MARKETS BY AROUND 100 TO 200 BASIS POINTS PER YEAR

SARTORIUS AG -  2027 ONWARDS: EXPECTS COMPANY TO OUTGROW ITS ADDRESSABLE MARKETS BY AROUND 100 TO 200 BASIS POINTS PER YEAR

SARTORIUS AG - OUTLOOK FROM 2027 ONWARDS: ORGANIC SALES REVENUE GROWTH IN CONSTANT CURRENCIES OF 8 TO 11 PERCENT PER YEAR AT GROUP LEVEL.

Source text: [ID:]

Further company coverage: SATG.DE

 ((frankfurt.newsroom@thomsonreuters.com;))